Yuhan Corp. - Asset Resilience Ratio

Latest as of December 2025: 0.92%

Yuhan Corp. (000100) has an Asset Resilience Ratio of 0.92% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Yuhan Corp. to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩29.52 Billion
≈ $20.00 Million USD Cash + Short-term Investments

Total Assets

₩3.22 Trillion
≈ $2.18 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Yuhan Corp.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Yuhan Corp. assets under control.

Liquid Assets Composition Over Time

This chart breaks down Yuhan Corp.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Yuhan Corp. strategic investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩29.52 Billion 0.92%
Total Liquid Assets ₩29.52 Billion 0.92%

Asset Resilience Insights

  • Limited Liquidity: Yuhan Corp. maintains only 0.92% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Yuhan Corp. Industry Peers by Asset Resilience Ratio

Compare Yuhan Corp.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Viatris Inc
NASDAQ:VTRS
Drug Manufacturers - Specialty & Generic 1.48%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 4.31%
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
Drug Manufacturers - Specialty & Generic 1.01%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Drug Manufacturers - Specialty & Generic 5.90%

Annual Asset Resilience Ratio for Yuhan Corp. (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Yuhan Corp..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.92% ₩29.52 Billion
≈ $20.00 Million
₩3.22 Trillion
≈ $2.18 Billion
+0.09pp
2024-12-31 0.82% ₩24.23 Billion
≈ $16.42 Million
₩2.94 Trillion
≈ $1.99 Billion
+0.01pp
2023-12-31 0.81% ₩22.75 Billion
≈ $15.41 Million
₩2.81 Trillion
≈ $1.91 Billion
-1.40pp
2022-12-31 2.21% ₩54.68 Billion
≈ $37.06 Million
₩2.47 Trillion
≈ $1.68 Billion
-5.22pp
2021-12-31 7.44% ₩183.22 Billion
≈ $124.16 Million
₩2.46 Trillion
≈ $1.67 Billion
+3.59pp
2020-12-31 3.85% ₩92.11 Billion
≈ $62.42 Million
₩2.39 Trillion
≈ $1.62 Billion
-2.81pp
2019-12-31 6.66% ₩140.94 Billion
≈ $95.51 Million
₩2.12 Trillion
≈ $1.43 Billion
-4.10pp
2018-12-31 10.76% ₩233.84 Billion
≈ $158.47 Million
₩2.17 Trillion
≈ $1.47 Billion
-0.94pp
2017-12-31 11.70% ₩245.00 Billion
≈ $166.03 Million
₩2.09 Trillion
≈ $1.42 Billion
-0.11pp
2016-12-31 11.81% ₩241.58 Billion
≈ $163.71 Million
₩2.05 Trillion
≈ $1.39 Billion
+10.18pp
2015-12-31 1.63% ₩30.66 Billion
≈ $20.78 Million
₩1.88 Trillion
≈ $1.27 Billion
-15.20pp
2014-12-31 16.83% ₩271.99 Billion
≈ $184.32 Million
₩1.62 Trillion
≈ $1.10 Billion
+11.27pp
2013-12-31 5.56% ₩84.16 Billion
≈ $57.03 Million
₩1.51 Trillion
≈ $1.03 Billion
-5.54pp
2012-12-31 11.10% ₩155.80 Billion
≈ $105.58 Million
₩1.40 Trillion
≈ $950.85 Million
+0.19pp
2011-12-31 10.92% ₩143.48 Billion
≈ $97.23 Million
₩1.31 Trillion
≈ $890.52 Million
-5.38pp
2010-12-31 16.30% ₩204.61 Billion
≈ $138.66 Million
₩1.26 Trillion
≈ $850.84 Million
+8.95pp
2009-12-31 7.35% ₩83.35 Billion
≈ $56.49 Million
₩1.13 Trillion
≈ $769.03 Million
-0.69pp
2008-12-31 8.04% ₩83.48 Billion
≈ $56.58 Million
₩1.04 Trillion
≈ $704.04 Million
+0.72pp
2007-12-31 7.31% ₩72.94 Billion
≈ $49.43 Million
₩997.19 Billion
≈ $675.78 Million
+2.23pp
2006-12-31 5.09% ₩47.91 Billion
≈ $32.47 Million
₩941.40 Billion
≈ $637.97 Million
-4.19pp
2005-12-31 9.28% ₩83.42 Billion
≈ $56.54 Million
₩898.67 Billion
≈ $609.01 Million
+0.93pp
2004-12-31 8.35% ₩63.87 Billion
≈ $43.29 Million
₩764.90 Billion
≈ $518.36 Million
-0.88pp
2003-12-31 9.23% ₩60.90 Billion
≈ $41.27 Million
₩659.58 Billion
≈ $446.99 Million
-4.81pp
2002-12-31 14.04% ₩88.60 Billion
≈ $60.04 Million
₩631.04 Billion
≈ $427.64 Million
-1.03pp
2001-12-31 15.07% ₩87.95 Billion
≈ $59.60 Million
₩583.76 Billion
≈ $395.60 Million
-0.19pp
2000-12-31 15.25% ₩84.83 Billion
≈ $57.49 Million
₩556.14 Billion
≈ $376.89 Million
--
pp = percentage points

About Yuhan Corp.

KO:000100 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$3.87 Billion
₩5.71 Trillion KRW
Market Cap Rank
#4216 Global
#95 in Korea
Share Price
₩77500.00
Change (1 day)
+0.26%
52-Week Range
₩66400.00 - ₩125000.00
All Time High
₩163700.00
About

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more